Medications for Influenza Human

4 results

  • amantadine

    (amantadine)
    Alembic Pharmaceuticals Inc.
    Amantadine hydrochloride capsules are indicated for prophylaxis and treatment of influenza A virus infections and for treating parkinsonism and drug-induced extrapyramidal reactions. They are recommended during influenza outbreaks and in patients exhibiting parkinsonism symptoms, although they are less effective than some other treatments for Parkinson's disease.

  • amantadine hcl

    (AMANTADINE HYDROCHLORIDE)
    Bionpharma Inc.
    Amantadine Hydrochloride Capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for managing parkinsonism and drug-induced extrapyramidal reactions. Prophylaxis assists immune response development, but it’s not a substitute for vaccination. Effectiveness for other viral illnesses is not established.

  • oseltamivir

    (OSELTAMIVIR)
    Alembic Pharmaceuticals Inc.
    Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset. It is also used for prophylaxis in individuals 1 year and older. Vaccination is recommended annually and resistance may impact effectiveness.

  • oseltamivir phosphate

    (Oseltamivir phosphate)
    Lupin Pharmaceuticals Inc
    Oseltamivir phosphate is indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. It is also used for prophylaxis in individuals aged 1 year and older. It is not a substitute for vaccination.